跳至主要内容
临床试验/CTRI/2014/05/004586
CTRI/2014/05/004586招募中3 期

An assessor blind, parallel, multicentric randomized placebo-controlled study to demonstrate the efficacy and safety of Estradiol 10μg (Test product: Manufactured by Famy Care Ltd., India) with Vagifem® (Reference drug: Manufactured by Novo Nordisk Inc., USA) in healthy postmenopausal women with symptoms of vulvar and vaginal atrophy and no contraindication to estrogen therapy. - NA

Famy Care Ltd0 个研究点目标入组 465 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
465

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient should be able to give written informed consent
  • Patients should be Postmenopausal women with vaginal atrophy
  • At screening systolic blood pressure be no greater than 150 mm Hg and diastolic blood pressure be no greater than 90 mm Hg
  • Patient with no significant illness other than vaginal atrophy as judged by the Investigator
  • Ability to comply with requirements of trial

排除标准

  • Known or suspected allergy to estrogen or any of its excipients
  • Known or suspected history of breast carcinoma, Estrogen-dependent neoplasia
  • Genital bleeding of unknown cause
  • Acute thrombophlebitis or thromboembolic disorder associated with estrogen use
  • Known history of drug or alcohol abuse

研究者

发起方
Famy Care Ltd

相似试验